Six years ago Abiraterone was hailed as a medical breakthrough that could offer men extra time with loved ones and a chance to delay chemotherapy and its debilitating side effects.
Today the body that recommends what can and cannot be paid for said it 'wasn't cost effective'.
Prostate cancer patients have now been told that the life-extending drug will not be routinely prescribed unless they have chemotherapy.
One man from North Yorkshire who is fighting prostate cancer is calling for a rethink:
More top news
Former Hull FC star Tom Briscoe scored five tries to see Leeds Rhinos retain the Challenge cup with a record 50-0 win over Hull KR.
Labour leadership candidate says Britain playing its role in the migrant crisis would help Cameron secure the promised reforms in Brussels.
The Rhinos lead Hull KR 16-0 at halftime in the Challenge Cup final.